"Immunotherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.
| Descriptor ID |
D007167
|
| MeSH Number(s) |
E02.095.465.425
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunotherapy".
Below are MeSH descriptors whose meaning is more specific than "Immunotherapy".
This graph shows the total number of publications written about "Immunotherapy" by people in this website by year, and whether "Immunotherapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2002 | 1 | 2 | 3 |
| 2003 | 4 | 2 | 6 |
| 2005 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 2 | 0 | 2 |
| 2010 | 3 | 1 | 4 |
| 2011 | 3 | 2 | 5 |
| 2013 | 3 | 2 | 5 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 3 | 3 |
| 2016 | 4 | 1 | 5 |
| 2017 | 5 | 1 | 6 |
| 2018 | 5 | 8 | 13 |
| 2019 | 5 | 3 | 8 |
| 2020 | 4 | 7 | 11 |
| 2021 | 2 | 6 | 8 |
| 2022 | 2 | 9 | 11 |
| 2023 | 0 | 1 | 1 |
| 2024 | 2 | 5 | 7 |
| 2025 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunotherapy" by people in Profiles.
-
Shared HLA-Bound Neoepitopes Are New Targets for Pancreatic Cancer Immunotherapy. Clin Cancer Res. 2025 May 15; 31(10):1821-1823.
-
New Frontiers in Multiple Sclerosis Treatment: From Targeting Costimulatory Molecules to Bispecific Antibodies. Int J Mol Sci. 2025 Apr 19; 26(8).
-
Targeting lactylation and the STAT3/CCL2 axis to overcome immunotherapy resistance in pancreatic ductal adenocarcinoma. J Clin Invest. 2025 Apr 01; 135(7).
-
Cellular plasticity and non-small cell lung cancer: role of T and NK cell immune evasion and acquisition of resistance to immunotherapies. Cancer Metastasis Rev. 2025 Jan 25; 44(1):27.
-
The Utilization of PRAME in the Diagnosis, Prognosis, and Treatment of Melanoma. Cells. 2024 Oct 20; 13(20).
-
Localized ablative immunotherapy enhances antitumor immunity by modulating the transcriptome of tumor-infiltrating Gamma delta T cells. Cancer Lett. 2024 Nov 01; 604:217267.
-
Immunogenic Treatment of Metastatic Breast Cancer Using Targeted Carbon Nanotube Mediated Photothermal Therapy in Combination with Anti-Programmed Cell Death Protein-1. J Pharmacol Exp Ther. 2024 Jun 21; 390(1):65-77.
-
Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy. Cell Metab. 2024 Jul 02; 36(7):1521-1533.e5.
-
Protein Arginine Methyltransferases in Pancreatic Ductal Adenocarcinoma: New Molecular Targets for Therapy. Int J Mol Sci. 2024 Apr 02; 25(7).
-
Modulating tumoral exosomes and fibroblast phenotype using nanoliposomes augments cancer immunotherapy. Sci Adv. 2024 Mar; 10(9):eadk3074.